Venlafaxin Bluefish 150 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

venlafaxin bluefish 150 mg

bluefish pharmaceuticals ab - venlafaksinhydroklorid - depotkapsel, hard - 150 mg

Xeomin 100 E Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

xeomin 100 e

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 100 e

Xeomin 50 E Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

xeomin 50 e

merz pharmaceuticals gmbh, frankfurt, tyskland - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 50 e

Xeomin 200 E Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

xeomin 200 e

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 200 e

Nyxthracis (previously Obiltoxaximab SFL) Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Thiotepa Riemser Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Bocouture 50 E Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

bocouture 50 e

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 50 e

Bocouture 100 E Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

bocouture 100 e

merz pharmaceuticals gmbh - botulinumtoksin type a - pulver til injeksjonsvæske, oppløsning - 100 e

Teriflunomide Mylan Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Trobalt Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

trobalt

glaxo group limited  - retigabin - epilepsi - antiepileptics, - trobalt angis som tilleggsbehandling behandling av stoff-resistent delvis-utbruddet anfall med eller uten sekundær generalisering hos pasienter 18 år eller eldre med epilepsi, der andre aktuelle rusmiddelkombinasjoner har vist seg utilstrekkelig eller er ikke tolerert.